Acute & Chronic Myeloid Leukemias neoplastic cells of the hemopoietic system

Acute & Chronic Myeloid Leukemias

Acute & Chronic Myeloid Leukemias ,The myeloid leukemias are a group of diseases with infiltration of blood, bone-marrow and other tissues by neoplastic cells of the hemopoietic system

 

 

Acute & Chronic Myeloid Leukemias 4
Acute & Chronic Myeloid Leukemias

 

Acute & Chronic Myeloid Leukemias

  • The myeloid leukemias are a group of diseases with infiltration of blood, bone-marrow and other tissues by neoplastic cells of the hemopoietic system.

ACUTE MYELOID LEUKEMIA

  • Incidence is higher in men than in women. Incidence increases with age.
Acute & Chronic Myeloid Leukemias 3
Etiolog

 

Acute & Chronic Myeloid Leukemias Etiology –

Acute & Chronic Myeloid Leukemias Classification –

  • Acute leukemias are classified on basis of morphology, cytochemistry, cytogenetics and molecular techniques.

Clinical presentation Acute & Chronic Myeloid Leukemias

  • Patients with AML(acute myeloid leukemia) present with non-specific symp­toms, gradually or abruptly.
  • Presentation may be due to anaemia, leukocytosis, leukopenia, or thrombocytopenia.

Acute & Chronic Myeloid Leukemias Symptoms –

Acute & Chronic Myeloid Leukemias Physical findings –

 

Hematological findings

 

Acute & Chronic Myeloid Leukemias 1
Hematological findings

 

  • Anaemia – usually normocytic, normochromic. Reduced reticulocyte count.
  • Leukocyte count may be 15,000 to 100,000 or some­times more than even 100,000/1J1.
  • 20 – 40 per cent of patients have leucocyte count less than 5000/1J1.

 

FAB (French-American-British) classification of AML

Acute & Chronic Myeloid Leukemias Treatment

Complete remission (CR)

  • CR is defined as absence of blast cells in circulation. Blood neutrophil count must be more than 1500/1J1. Platelet count must be more than 100,000/ IJI. Bone-marrow should contain less than 5% blast cells. Auer rods should be absent.
  • Standard therapy is 7-day continuous infusion of Cytarabine 100 – 200 mg /sq m / day.
  • Patients who achieve CR must be given consolidation therapy with sequential courses of Cytarabine in high doses and allogenic stem cell transplant.
  • Patients with APL (acute promyeiocytic leukemia) should receive Tretinoin with anthracycline chemo­therapy (Daunorubicin), and then consolidation che­motherapy with Daunorubicin and Cytarabine, fol­lowed by maintenance with tretinoin.
  • ClinicalGlycogen Storage Diseases von Gierke disease, Andersen's disease, McArdle's disease. Read more ... » trials with recombinant hemopoietic growth factors are going on.

Acute & Chronic Myeloid Leukemias Supportive care

  • with blood transfusion, platelet transfusion, broad-spectrum antibacterials, and an­tifungals are given.

CHRONIC MYELOGENOUS I MYELOID LEUKEMIA

Etiology is same as AML

  • Clinical presentation Onset is slow, with patients often asymptomatic at diagnosis.
  • There is fatigue, malaise, weight loss, splenomegaly, infections, thrombosis, bleeding, cerebrovascular ac­cidents, MI, venous thrombosis, bone and joint pains, splenomegaly, hepatomegaly, lymphadenopathy.

Acute & Chronic Myeloid Leukemias Hematological findings

  • White blood cells counts are grossly elevated, imma­ture granulocytes are seen in circulating blood, but small in number i.e. less than 5% blasts and less than 10% promyelocytes are seen in circulating blood.
  • Platelet counts may be elevated
  • There is increased bone marrow cellularity, of my­eloid and megakaryocytic types.
  • Disease acceleration is defined as increasing anaemia, blood or marrow blasts between 10 and 20%, blood or marrow basophils >20%, platelet count less than 100,000/1-11.
  • Blast crisis is defined as acute leukemia with blood or marrow blasts more than 20%.

Acute & Chronic Myeloid Leukemias Treatment

  • Allogenic stem cell transplant or treatment with ImatinibInterferon
  • Chemotherapy with hydroxyurea, 1-4 g/day, halved when leucocyte count reduces by 50%
  • Busulphan : alkylating agent, with serious side­effects and therefore not used nowadays
  • HHT — Homoharringtonine is a plant alkaloid from Cephalotaxus tree
  • Leukapheresis and splenectomy

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title="" rel=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>